Mirodenafil administration reversed memory dysfunction in APP-C105 transgenic mice, as confirmed by the improved cognitive-behavioral performances during the Morris water maze and passive avoidance tests (Fig. 1A–F), suggesting that mirodenafil was able to rescue hippocampus-associated cognitive impairments in the AD model mice. Here, APP is linked to Alzheimer disease.